Certified Global Research Member

Isomar fd.webp

Wcrc 57.webp

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players’ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Pdf download

Ticagrelor Market Research Report Information by Dosage (Mg) (90 MG and 60 MG), Route of Administration (Oral and Nasogastric Tube), Application (Acute Coronary Syndrome and Heart Surgeries (Angioplasty, Stent Placement and Coronary Artery Bypass Graft)) End User (Hospitals and Clinics and Ambulatory Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2032

ID: MRFR/Pharma/0324-CR | 101 Pages | Author: Kinjoll Dey| July 2019

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 Report Prologue

2 Introduction

2.1 Definition 14

2.2 Scope of the Study 14

2.3 Research Objective 14

2.4 Assumptions & Limitations 14

2.4.1 Assumptions 14

2.4.2 Limitations 14

2.4.3 Market Structure 14

3 Research Methodology

3.1 Primary Research Methodology 16

3.2 Secondary Research Methodology 18

3.3 Market Size Estimation 19

3.4 Forecast Model 19

4 Market Dynamics

4.1 Drivers 21

4.1.1 Rising Cardiovascular Disorders 21

4.1.2 Increasing Geriatric Population 22

4.2 Restraints 22

4.2.1 High Bleeding Complications 22

4.3 Opportunities 22

4.3.1 Exploring New Applications 22

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 24

5.1.1 Bargaining Power of Suppliers 24

5.1.2 Bargaining Power of Buyers 25

5.1.3 Threat of New Entrants 25

5.1.4 Threat of Substitutes 25

5.1.5 Intensity of Rivalry 25

5.2 Value Chain Analysis 26

5.2.1 R&D 26

5.2.2 Manufacturing 26

5.2.3 Distribution & Sales 26

5.2.4 Post-Sales Monitoring 26

5.3 Demand & Supply: Gap Analysis 27

5.4 Pricing Analysis 27

5.5 Investment Opportunities 27

5.6 Macroeconomic Indicators 27

5.7 Pipeline Analysis 28

6 The Global Ticagrelor Market, by Dosage (Mg)

6.1 Introduction 30

6.2 90 MG 31

6.3 60 MG 31

7 The Ticagrelor Market, by Route of Administration

7.1 Introduction 33

7.2 Oral 34

7.3 Nasogastric Tube 34

8 The Ticagrelor Market, by Application

8.1 Introduction 36

8.2 Acute Coronary Syndrome 37

8.3 Heart Surgeries 37

8.3.1 Angioplasty 38

8.3.2 Stent Placement 38

8.3.3 Coronary Artery Bypass Graft 39

9 The Ticagrelor Market, by End User

9.1 Introduction 41

9.2 Hospitals and Clinics 42

9.3 Ambulatory Centers 42

10 The Global Ticagrelor Market, by Region

10.1 Introduction 44

10.2 Americas 46

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.2.1 North America 48

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.2.1.1 US 50

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.2.1.2 Canada 52

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.2.2 South America 54

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3 Europe 56

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.1 Western Europe 58

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.1.1 Germany 60

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.1.2 UK 62

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.1.3 France 63

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.1.4 Italy 65

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.1.5 Spain 67

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.1.6 Rest of Western Europe 68

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.3.2 Eastern Europe 70

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.4 Asia-Pacific 72

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.4.1 Japan 74

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.4.2 China 76

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.4.3 India 77

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.4.4 Australia 79

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.4.5 South Korea 81

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.4.6 Rest of Asia-Pacific 82

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.5 Rest of the World 85

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.5.1 Middle East 87

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.5.2 Africa 89

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

10.5.3 Other Countries 90

The Ticagrelor Market, by Route of Administration

The Ticagrelor Market, by Application

The Ticagrelor Market, by End User

11 Company Landscape

11.1 Introduction 94

12 Company Profiles

12.1 AstraZeneca, PLC 96

12.1.1 Company Overview 96

12.1.2 Financial Overview 96

12.1.3 Products Offering 97

12.1.4 Key Developments 97

12.1.5 SWOT Analysis 97

12.1.6 Key Strategy 97

13 Appendix

13.1 Discussion Blue Print 99

13.2 References 100

14 List of Tables

TABLE 1 PRIMARY INTERVIEWS 17

TABLE 2 PIPELINE PRODUCTS 28

TABLE 3 GLOBAL TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 30

TABLE 4 GLOBAL TICAGRELOR MARKET FOR 90 MG, BY REGION, 2023–2030 (USD MILLION) 31

TABLE 5 GLOBAL TICAGRELOR MARKET FOR 60 MG, BY REGION, 2023–2030 (USD MILLION) 31

TABLE 6 GLOBAL TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 33

TABLE 7 GLOBAL TICAGRELOR MARKET FOR ORAL, BY REGION, 2023–2030 (USD MILLION) 34

TABLE 8 GLOBAL TICAGRELOR MARKET FOR NASOGASTRIC TUBE, BY REGION, 2023–2030 (USD MILLION) 34

TABLE 9 GLOBAL TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 36

TABLE 10 GLOBAL TICAGRELOR MARKET FOR ACUTE CORONARY SYNDROME, BY REGION, 2023–2030 (USD MILLION) 37

TABLE 11 GLOBAL TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 37

TABLE 12 GLOBAL TICAGRELOR MARKET FOR HEART SURGERIES, BY REGION 2023-2030 (USD MILLION) 38

TABLE 13 GLOBAL TICAGRELOR MARKET FOR ANGIOPLASTY, BY REGION, 2023–2030 (USD MILLION) 38

TABLE 14 GLOBAL TICAGRELOR MARKET FOR STENT PLACEMENT, BY REGION, 2023–2030 (USD MILLION) 38

TABLE 15 GLOBAL TICAGRELOR MARKET FOR CORONARY ARTERY BYPASS GRAFT-, BY REGION, 2023–2030 (USD MILLION) 39

TABLE 16 GLOBAL TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 41

TABLE 17 GLOBAL TICAGRELOR MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2023–2030 (USD MILLION) 42

TABLE 18 GLOBAL TICAGRELOR MARKET FOR AMBULATORY CENTERS, BY REGION, 2023–2030 (USD MILLION) 42

TABLE 19 GLOBAL TICAGRELOR MARKET, BY REGION 2023-2030 (USD MILLION) 45

TABLE 20 AMERICAS TICAGRELOR MARKET, BY REGION 2023-2030 (USD MILLION) 46

TABLE 21 AMERICAS TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 46

TABLE 22 AMERICAS TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 47

TABLE 23 AMERICAS TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 47

TABLE 24 AMERICAS TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 47

TABLE 25 AMERICAS TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 48

TABLE 26 NORTH AMERICA TICAGRELOR MARKET, BY COUNTRY 2023-2030 (USD MILLION) 48

TABLE 27 NORTH AMERICA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 49

TABLE 28 NORTH AMERICA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 49

TABLE 29 NORTH AMERICA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 49

TABLE 30 NORTH AMERICA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 49

TABLE 31 NORTH AMERICA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 50

TABLE 32 US TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 50

TABLE 33 US TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 50

TABLE 34 US TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 51

TABLE 35 US TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 51

TABLE 36 US TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 51

TABLE 37 CANADA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 52

TABLE 38 CANADA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 52

TABLE 39 CANADA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 52

TABLE 40 CANADA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 53

TABLE 41 CANADA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 53

TABLE 42 SOUTH AMERICA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 54

TABLE 43 SOUTH AMERICA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 54

TABLE 44 SOUTH AMERICA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 54

TABLE 45 SOUTH AMERICA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 55

TABLE 46 SOUTH AMERICA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 55

TABLE 47 EUROPE TICAGRELOR MARKET, BY REGION 2023-2030 (USD MILLION) 56

TABLE 48 EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 56

TABLE 49 EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 57

TABLE 50 EUROPE TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 57

TABLE 51 EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 57

TABLE 52 EUROPE TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 58

TABLE 53 WESTERN EUROPE TICAGRELOR MARKET, BY COUNTRY 2023-2030 (USD MILLION) 58

TABLE 54 WESTERN EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 59

TABLE 55 WESTERN EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 59

TABLE 56 WESTERN EUROPE TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 59

TABLE 57 WESTERN EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 59

TABLE 58 WESTERN EUROPE TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 60

TABLE 59 GERMANY TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 60

TABLE 60 GERMANY TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 60

TABLE 61 GERMANY TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 61

TABLE 62 GERMANY TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 61

TABLE 63 GERMANY TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 61

TABLE 64 UK TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 62

TABLE 65 UK TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 62

TABLE 66 UK TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 62

TABLE 67 UK TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 63

TABLE 68 UK TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 63

TABLE 69 FRANCE TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 63

TABLE 70 FRANCE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 64

TABLE 71 FRANCE TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 64

TABLE 72 FRANCE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 64

TABLE 73 FRANCE TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 65

TABLE 74 ITALY TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 65

TABLE 75 ITALY TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 65

TABLE 76 ITALY TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 66

TABLE 77 ITALY TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 66

TABLE 78 ITALY TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 66

TABLE 79 SPAIN TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 67

TABLE 80 SPAIN TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 67

TABLE 81 SPAIN TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 67

TABLE 82 SPAIN TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 68

TABLE 83 SPAIN TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 68

TABLE 84 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 68

TABLE 85 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 69

TABLE 86 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 69

TABLE 87 REST OF WESTERN EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 69

TABLE 88 REST OF WESTERN EUROPE TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 70

TABLE 89 EASTERN EUROPE TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 70

TABLE 90 EASTERN EUROPE TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 70

TABLE 91 EASTERN EUROPE TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 71

TABLE 92 EASTERN EUROPE TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 71

TABLE 93 EASTERN EUROPE TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 71

TABLE 94 ASIA-PACIFIC TICAGRELOR MARKET, BY COUNTRY 2023-2030 (USD MILLION) 72

TABLE 95 ASIA-PACIFIC TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 72

TABLE 96 ASIA-PACIFIC TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 73

TABLE 97 ASIA-PACIFIC TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 73

TABLE 98 ASIA-PACIFIC TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 73

TABLE 99 ASIA-PACIFIC TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 74

TABLE 100 JAPAN TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 74

TABLE 101 JAPAN TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 74

TABLE 102 JAPAN TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 75

TABLE 103 JAPAN TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 75

TABLE 104 JAPAN TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 75

TABLE 105 CHINA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 76

TABLE 106 CHINA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 76

TABLE 107 CHINA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 76

TABLE 108 CHINA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 77

TABLE 109 CHINA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 77

TABLE 110 INDIA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 77

TABLE 111 INDIA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 78

TABLE 112 INDIA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 78

TABLE 113 INDIA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 78

TABLE 114 INDIA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 79

TABLE 115 AUSTRALIA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 79

TABLE 116 AUSTRALIA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 79

TABLE 117 AUSTRALIA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 80

TABLE 118 AUSTRALIA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 80

TABLE 119 AUSTRALIA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 80

TABLE 120 SOUTH KOREA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 81

TABLE 121 SOUTH KOREA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 81

TABLE 122 SOUTH KOREA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 81

TABLE 123 SOUTH KOREA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 82

TABLE 124 SOUTH KOREA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 82

TABLE 125 REST OF ASIA-PACIFIC TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 82

TABLE 126 REST OF ASIA-PACIFIC TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 83

TABLE 127 REST OF ASIA-PACIFIC TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 83

TABLE 128 REST OF ASIA-PACIFIC TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 83

TABLE 129 REST OF ASIA-PACIFIC TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 84

TABLE 130 REST OF THE WORLDTICAGRELOR MARKET, BY REGION 2023-2030 (USD MILLION) 85

TABLE 131 REST OF THE WORLDTICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 85

TABLE 132 REST OF THE WORLDTICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 86

TABLE 133 REST OF THE WORLDTICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 86

TABLE 134 REST OF THE WORLDTICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 86

TABLE 135 REST OF THE WORLDTICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 87

TABLE 136 MIDDLE EAST TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 87

TABLE 137 MIDDLE EAST TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 87

TABLE 138 MIDDLE EAST TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 88

TABLE 139 MIDDLE EAST TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 88

TABLE 140 MIDDLE EAST TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 88

TABLE 141 AFRICA TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 89

TABLE 142 AFRICA TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 89

TABLE 143 AFRICA TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 89

TABLE 144 AFRICA TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 90

TABLE 145 AFRICA TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 90

TABLE 146 OTHER COUNTRIES TICAGRELOR MARKET, BY DOSAGE (MG) 2023-2030 (USD MILLION) 90

TABLE 147 OTHER COUNTRIES TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023-2030 (USD MILLION) 91

TABLE 148 OTHER COUNTRIES TICAGRELOR MARKET, BY APPLICATION 2023-2030 (USD MILLION) 91

TABLE 149 OTHER COUNTRIES TICAGRELOR MARKET FOR HEART SURGERIES, BY TYPE 2023-2030 (USD MILLION) 91

TABLE 150 OTHER COUNTRIES TICAGRELOR MARKET, BY END-USER 2023-2030 (USD MILLION) 92

15 List of Figures

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES 19

FIGURE 2 MARKET DYNAMICS: GLOBAL TICAGRELOR MARKET 21

FIGURE 3 PORTER’S FIVE FORCES ANALYSIS: GLOBAL TICAGRELOR MARKET 24

FIGURE 4 VALUE CHAIN ANALYSIS OF THE GLOBAL TICAGRELOR MARKET 26

FIGURE 5 GLOBAL TICAGRELOR MARKET, BY DOSAGE (MG) 2023 & 2030 (USD MILLION) 30

FIGURE 6 GLOBAL TICAGRELOR MARKET, BY ROUTE OF ADMINISTRATION 2023 & 2030 (USD MILLION) 33

FIGURE 7 GLOBAL TICAGRELOR MARKET, BY APPLICATION 2023 & 2030 (USD MILLION) 36

FIGURE 8 GLOBAL TICAGRELOR MARKET, FOR HEART SURGERIES BY TYPE 2023 & 2030 (USD MILLION) 37

FIGURE 9 GLOBAL TICAGRELOR MARKET, BY END-USER 2023 & 2030 (USD MILLION) 41

FIGURE 10 GLOBAL TICAGRELOR MARKET, BY REGION 2023 & 2030 (USD MILLION) 45

FIGURE 11 AMERICAS TICAGRELOR MARKET SHARE, BY REGION 2023 (%) 46

FIGURE 12 AMERICAS TICAGRELOR MARKET SHARE, BY COUNTRY 2023 (%) 48

FIGURE 13 EUROPE TICAGRELOR MARKET, BY REGION 2023 (%) 56

FIGURE 14 WESTERN EUROPE TICAGRELOR MARKET, BY COUNTRY 2023 (%) 58

FIGURE 15 ASIA-PACIFIC TICAGRELOR MARKET, BY COUNTRY 2023 (%) 72

FIGURE 16 REST OF THE WORLDTICAGRELOR MARKET, BY REGION 2023(%) 85

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Press Release

pr-img

Global Ticagrelor Market Projected To Grow Radiantly By 2032; Asserts MRFR Unleashing Industry Fo...

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)